Finance

Lists
Why is TTRX up 7.31%?
Dive Deeper
TTRX:NASDAQ
Turn Therapeutics Inc
$14.39
+7.31%
(+0.98) 1D
$14.39
0.00% (0.00)
After hours
Closed: Sep 30, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TTRX...
Open
$13.41
High
$14.63
Low
$13.02
Mkt. cap
438.93M
Avg. vol.
132.08K
Volume
88.72K
52-wk high
$26.50
52-wk low
$2.57
EPS
-$0.29
Shares outstanding
29.79M
No. of employees
2
Open
$13.41
High
$14.63
Low
$13.02
Mkt. cap
438.93M
Avg. vol.
132.08K
Volume
88.72K
52-wk high
$26.50
52-wk low
$2.57
EPS
-$0.29
Shares outstanding
29.79M
No. of employees
2
News stories
From web sources and news partners
About Turn Therapeutics Inc
CEO-
Employees2
Founded2015
HeadquartersWestlake Village, California, United States
SectorPharmaceutical industry
Websiteturntherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to TTRX in the past 3 months
Hold
Buy
2
Hold
0
Sell
2
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for TTRX in the last 3 months.
Highest
Current $14.39
$24.00 (+66.78%)
Average
$15.00 (+4.24%)
Lowest
$10.00 (-30.51%)
Analyst
Recommendation
Action
Price target
Projected
Date
Dev Prasad
Lucid Capital
Buy
Initiated
$24.00
+66.8%
09/24/2026
Karen Sterling
Westpark Capital
Sell
Downgraded
$10.00
-30.5%
09/14/2026
Unknown Analyst
WBB Securities
Sell
Downgraded
$10.00
-30.5%
09/14/2026
Rick Bienkowski
Ladenburg Thalmann & Co.
Buy
Maintained
$16.00
+11.2%
08/13/2026
Jason Kolbert
D. Boral Capital
Buy
Initiated
$8.00
-44.4%
12/29/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
496.95K
477.65K
638.75K
Cost of revenue
-
496.95K
477.65K
638.75K
Research and development expenses
158.70K
34.93K
109.43K
475.06K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.75M
2.16M
1.14M
1.15M
Operating expense
1.91M
2.19M
1.25M
1.63M
Total operating expenses
1.91M
2.69M
1.72M
2.27M
Operating income
-1.91M
-2.69M
-1.72M
-2.27M
Other non operating income
4.26K
2.96M
703.14K
-3.34M
EBT including unusual items
-1.90M
279.07K
-970.97K
-5.85M
EBT excluding unusual items
-1.90M
279.07K
-970.97K
-5.85M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.90M
279.07K
-970.97K
-5.85M
Net profit margin
-
-
-
-
Earnings per share
-
-
-0.04
-
Interest and investment income
5.11K
14.18K
49.68K
-
Interest expense
-
-
-
-241.36K
Net interest expenses
5.11K
14.18K
49.68K
-241.36K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.90M
-2.68M
-1.71M
-2.25M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps